OCULAR THERAPEUTIX, INC Balance Sheet
OCUL / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
OCULAR THERAPEUTIX, INC had $808M in total assets and $654M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $737.1M | $392.1M | $195.8M | $164.2M | $228.1M | $54.4M | $54.1M | $54.1M | $41.5M | $32.9M | $17.5M | $23.9M | $17.5M | $23.9M |
| Accounts Receivable | $30.6M | $32.4M | $26.2M | $21.3M | $21.1M | $12.3M | $2.5M | $201.0K | $226.0K | $250.0K | $193.0K | $329.0K | $250.0K | - |
| Inventory | $3.6M | $3.0M | $2.3M | $2.0M | $1.3M | $1.2M | $954.0K | $217.0K | $122.0K | $113.0K | $134.0K | $133.0K | - | - |
| Current Assets | $782.1M | $441.0M | $232.2M | $129.6M | $191.3M | $246.2M | $60.2M | $56.2M | $43.3M | $69.9M | $107.0M | $76.2M | $18.0M | - |
| PP&E (Net) | $19.7M | $9.4M | $11.7M | $9.9M | $7.0M | $8.1M | $10.2M | $10.2M | $10.5M | $3.3M | $3.1M | $1.8M | $904.0K | - |
| Total Assets | $808.1M | $457.9M | $252.1M | $149.3M | $204.9M | $261.9M | $78.7M | $73.0M | $55.4M | $74.9M | $110.3M | $78.2M | $19.1M | - |
| Current Liabilities | $50.8M | $41.4M | $34.9M | $31.4M | $26.3M | $26.7M | $12.0M | $9.2M | $13.4M | $8.3M | $5.4M | $5.9M | $3.3M | - |
| Shareholders' Equity | $654.3M | $315.3M | $91.1M | $76.1M | -$3.6M | $35.9M | $35.9M | $35.9M | $26.1M | $52.0M | -$59.5M | -$46.6M | -$59.5M | -$46.6M |